Latest Breaking News On - Yong zu kim - Page 1 : comparemela.com

Samsung Biologics and LegoChem enter ADC development deal

Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.

Legochem biosciencesSamsung biologicsDrug administrationSamsung life science fundSamsung biologicLegochem bioscienceInvestigational new drugYong zu kimChem biosciencesKurma partnersKurma partnerJohn rim

Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing

- Samsung Biologics to develop and manufacture antibody for ADC candidate - Latest deal comes as Samsung Biologics is on track to complete construction of an ADC facility this year INCHEON, South Korea, Feb. 7, 2024

South koreaInch on gwangyoksiSamsung biologicsClaire kimPrnewswire samsung biologicsDaeyoung jeongSamsung biologics americaLegochem biosciencesSamsung life science fundTeam leaderLegochem biosciences incHead of marketing communicationsSamsung biologics co ltdLegochem bioscienceChem biosciencesInvestigational new drug

LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC

DAEJEON, South Korea, December 26, 2023 LegoChem Biosciences Announces License Agreement for LCB84, a Trop2 directed ADC with Janssen Biotech, Inc., a Johnson & Johnson company.

Taejon gwangyoksiSouth koreaMediterranea theranosticYongzu kimLegochem biosciencesJanssen biotech incLegochem biosciences incJanssen biotechYong zu kimChem biosciencesUpfront paymentJanssen biotech

CORRECTING and REPLACING LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC

CORRECTING and REPLACING LegoChem Biosciences Announces License Agreement for LCB84 Trop2-Targeted ADC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Daeyoung jeongLegochem biosciencesMediterranea theranosticJanssen biotech incLegochem biosciences incChem biosciencesJanssen biotechYong zu kim

LegoChem Biosciences Enters Worldwide Licensing Agreement with Glycotope for Antibody Drug Conjugate Development

LegoChem Biosciences Enters Worldwide Licensing Agreement with Glycotope for Antibody Drug Conjugate Development
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiLegochem biosciencesHenner kollenbergGlycotope gmbDae young jeongPatrik kehlerChris welshGlycotope gmbhChris gardnerConsilium strategic communicationsAntibody drug conjugate developmentLegochem biosciences incAntibody drug conjugateGermany octoberYong zu kim